Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

September 2026

Added to Dediabetes Sep 1, 2026RCTs

Dietary protein and fiber do not affect bone turnover in T2D

This study examined the effects of dietary protein and fiber on bone turnover in adults with abdominal obesity and type 2 diabetes, finding no significant changes in key bone turnover markers.

Interventions
whey protein 20g
Outcomes
Bone mineral density (BMD)Change in U-calcium excretionChange in plasma levels of Procollagen type 1 N-terminal propeptide (P1NP)+5 more
Added to Dediabetes Sep 1, 2026RCTs

Empagliflozin/linagliptin preserves renal function better than metformin/insulin

This study compared the renal hemodynamic effects of empagliflozin/linagliptin versus metformin/insulin glargine in type 2 diabetes patients, finding significant changes in renal function metrics.

Interventions
Empagliflozin and LinagliptinSequential addition of metformin followed by glipizide and insulin glargine
Outcomes
Change in Renal Plasma Flow (RPF)Change in Renal Vascular Resistance (RVR)Estimated glomerular filtration rate
Added to Dediabetes Sep 1, 2026RCTs

Exenatide does not affect renal function in type 2 diabetes

This study investigated the acute renal effects of exenatide in patients with type 2 diabetes, finding no significant impact on glomerular filtration rate.

Interventions
Exenatide
Outcomes
Blood glucoseChange in Renal Plasma Flow (RPF)Diastolic blood pressure+10 more
Added to Dediabetes Sep 1, 2026RCTs

Soluble fiber improves glycemic control in type 2 diabetes.

This study evaluated the effects of soluble fiber supplementation on glycemic control and body weight in type 2 diabetes patients, finding significant improvements in several metabolic parameters.

Interventions
Insoluble fiber supplementation
Outcomes
BMIC-peptideFasting blood sugar (FBS)+4 more
Added to Dediabetes Sep 1, 2026RCTs

SGLT2 Inhibitors Improve Vascular Compliance Despite Renal Function Decline

This study investigated the effects of SGLT2 inhibitors on renal function and vascular compliance, finding a significant initial decline in renal function linked to improved vascular compliance.

Interventions
Empagliflozin and LinagliptinSequential addition of metformin followed by glipizide and insulin glargine
Outcomes
Estimated glomerular filtration rateFemoral-ankle pulse wave velocity (faPWV) during acute hyperglycemia
Added to Dediabetes Sep 1, 2026RCTs

Sugar-free dark chocolate lowers blood glucose in diabetes

A study evaluated the effects of a sugar-free dark chocolate bar on blood glucose levels in diabetes, finding a significant reduction in the incremental area under the curve compared to conventional dark chocolate.

Interventions
Conventional dark chocolateSugar-free dark chocolate
Outcomes
C-peptide incremental area under the curve (iAUC)Glucose iAUC (OGTT)Peak glucose value after consumption of conventional dark chocolate+1 more
Added to Dediabetes Sep 1, 2026RCTs

Bardoxolone methyl improves kidney function in type 2 diabetes patients.

The Phase 2 study evaluated bardoxolone methyl in patients with chronic kidney disease and type 2 diabetes, showing a significant increase in GFR compared to placebo.

Interventions
Bardoxolone methyl
Outcomes
Glomerular filtration rate (GFR)Serious adverse eventsUrinary albumin-to-creatinine ratio

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.